US firms strike coating deal for embolic filter:
This article was originally published in Clinica
SurModics has finalised a licence agreement to use its hydrophilic coating technology on Rubicon Medical's catheter-based filter for capturing and removing embolic material that can become dislodged during interventional procedures to clear a blockage in a blood vessel. The firms believe that the coating could significantly enhance the deliverability of the Rubicon Filter with no measurable change to the small dimensions of the device. The Rubicon Filter, which captures embolic material downstream from a blockage, is the world's smallest-profile embolic filtration device, claims Salt Lake City, Utah-based Rubicon. It is targeted for use in saphenous vein grafts and carotid arteries. SurModics is an Eden Prairie, Minnesota-based firm that provides surface modification and drug delivery solutions.